ESC 365 - Dabigatran-induced esophagitis after radiofrequency catheter ablation

ESC Premium Access

Dabigatran-induced esophagitis after radiofrequency catheter ablation

Session: Drug treatment in patients with arrhythmia

Topic: Antiarrhythmic drugs

Speaker: Doctor Y. Ito (Tsukuba, JP)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Yoko Ito

Tsukuba Memorial Hospital, Tsukuba (Japan)

0 follower

7 more presentations in this session

Association between sociodemographic factors and choice of Direct Oral Anticoagulants versus warfarin in atrial fibrillation: A population based cross-sectional study using Swedish Registers

Speaker: Mr G. Brobert (Solna, SE)

Favorable effect of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with liver cirrhosis

Speaker: Doctor H. Yu (Seoul, KR)

Non-vitamin K antagonist oral anticoagulants in comparison to phenprocoumon in a real-word setting of atrial fibrillation: an analysis of a large german health claims dataset

Speaker: Mr C. Hohmann (Cologne, DE)

Increasing use of NOAC and antiplatelet combination therapy in atrial fibrillation following myocardial infarction or percutaneous coronary intervention

Speaker: Ms C. Clausen (Hellerup, DK)

Epicardial application of amiodarone-releasing hydrogel: experimental study

Speaker: Professor O. Bockeria (Moscow, RU)

Access the full session

Drug treatment in patients with arrhythmia

Speakers: Doctor Y. Ito, Mr G. Brobert, Doctor H. Yu, Mr C. Hohmann, Ms C. Clausen...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources